Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy

被引：0
|
作者：
Hata, Masayuki [1 ,2 ]
Tsujikawa, Akitaka [1 ,2 ]
Yoshimura, Nagahisa [1 ,2 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan
[2] Kagawa Univ, Fac Med, Dept Ophthalmol, 1750-1 Ikenobe,Miki Cho, Kagawa 7610793, Japan
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2016年 / 254卷 / 05期
关键词：
Optical Coherence Tomography; Ranibizumab; Fluorescein Angiography; Visual Outcome; Indocyanine Green;
D O I：
10.1007/s00417-015-3163-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1021 / 1022
页数：2
相关论文
共 50 条
  • [21] Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy
    Li, Meng-Syuan
    Tsen, Chui-Lien
    PLOS ONE, 2022, 17 (12):
  • [22] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    Akaza, Eriko
    Haruyama, Miho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (04) : 365 - 371
  • [23] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Ryusaburo Mori
    Mitsuko Yuzawa
    Eriko Akaza
    Miho Haruyama
    Japanese Journal of Ophthalmology, 2013, 57 : 365 - 371
  • [24] Visual prognosis of massive submacular hemorrhage in polypoidal choroidal vasculopathy with or without combination treatment
    Lin, Tai-Chi
    Hwang, De-Kuang
    Lee, Fenq-Lih
    Chen, Shih-Jen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (03) : 159 - 165
  • [25] FACTORS PREDICTIVE OF VISUAL ACUITY OUTCOMES 1 YEAR AFTER PHOTODYNAMIC THERAPY IN JAPANESE PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY
    Hikichi, Taiichi
    Ohtsuka, Hideo
    Higuchi, Makoto
    Matsushita, Takuro
    Ariga, Hiroko
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 857 - 865
  • [26] Visual Prognosis in the Better-seeing Eyes of Patients with Unilateral Polypoidal Choroidal Vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    OPTOMETRY AND VISION SCIENCE, 2019, 96 (09) : 686 - 694
  • [27] Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
    Fukuda, Yoshiko
    Sakurada, Yoichi
    Matsubara, Mio
    Hasebe, Yuka
    Sugiyama, Atsushi
    Kikushima, Wataru
    Kashiwagi, Kenji
    BIOMEDICINES, 2021, 9 (09)
  • [28] Combined Photodynamic Therapy With Intravitreal Bevacizumab Injections for Polypoidal Choroidal Vasculopathy: Long-term Visual Outcome
    Kang, Hae Min
    Koh, Hyoung Jun
    Lee, Christopher Seungkyu
    Lee, Sung Chul
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (03) : 598 - 606
  • [29] Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity
    De Salvo, Gabriella
    Thulasidharan, Suresh
    Barbara, Ramez
    Penwarden, Alison
    Aggarwal, Nishant
    Frisina, Rino
    EYE, 2024, 38 (16) : 3072 - 3076
  • [30] Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study
    Teo, Kelvin Yi Chong
    Park, Kyu-Hyung
    Ngah, Nor Fariza
    Chen, Shih-Jen
    Ruamviboonsuk, Paisan
    Mori, Ryusaburo
    Kondo, Nagako
    Lee, Won Ki
    Rajagopalan, Rajesh
    Obata, Ryo
    Wong, Ian Y. H.
    Chee, Caroline
    Terasaki, Hiroko
    Sekiryu, Tetsuju
    Chen, Shih-Chou
    Yanagi, Yasuo
    Honda, Shigeru
    Lai, Timothy Y. Y.
    Cheung, Chui Ming Gemmy
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (04) : 935 - 954
12345